Quantity vs. quality: Long-term use of bone-building osteoporosis drugs
Wednesday, March 10, 2010 - 08:42
in Health & Medicine
Bisphosphonate treatments, proven to enhance bone density and reduce fracture incidence in post-menopausal women, may adversely affect bone quality and increase risk of atypical fractures of the...
Read the whole article on Science Blog
More from Science Blog
Related
- Quantity vs. quality: Long-term use of bone-building osteoporosis drugsWed, 10 Mar 2010, 8:24:23 EST
- Long-term use of osteoporosis medication associated with increased risk of atypical fracturesTue, 22 Feb 2011, 17:22:20 EST
- New task force report on bisphosphonate use and atypical femur fractures in osteoporosis patientsTue, 14 Sep 2010, 0:42:35 EDT
- IOF and ESCEO position on atypical femoral fractures and long-term bisphosphonate useWed, 24 Nov 2010, 13:37:09 EST
- Taking a break from osteoporosis drugs can protect bonesThu, 18 Nov 2010, 14:53:33 EST